Press Release: KneeKG : Emovi is Accelerating its Growth Through a 15M$ Series C Investment Led by TVM Capital Life Science
MONTREAL, QUEBEC, CANADA, April 1, 2019 /EINPresswire.com/ -- Montreal, CANADA - April 1st, 2019 - Emovi announced today its partnership with TVM Capital Life Science and co-investors StandUp Ventures and Desjardins Capital to support its global ...
Read full article »
KneeKG is a knee assessment device that measures joint’s movement for the treatment of osteoarthritis and meniscus injuries.
Read more